INTEGER HOLDINGS CORPORATION Restructuring Costs
INTEGER HOLDINGS CORPORATION (ITGR) reported Restructuring Costs of $4.40 million for the 3-month period ending 2026-07-03, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:RestructuringCosts · last filed 2026-08-04
- INTEGER HOLDINGS CORPORATION restructuring costs for the quarter ending 2026-07-03 was $4.40M, a 70.76% increase year-over-year.
- INTEGER HOLDINGS CORPORATION restructuring costs for the quarter ending 2026-04-03 was $1.85M, a 67.70% increase year-over-year.
- INTEGER HOLDINGS CORPORATION restructuring costs for the quarter ending 2025-12-31 was $3.77M, a 148.32% increase year-over-year.
- INTEGER HOLDINGS CORPORATION restructuring costs for the quarter ending 2025-09-26 was $2.75M, a 43.48% increase year-over-year.
- INTEGER HOLDINGS CORPORATION restructuring costs for fiscal 2025 was $10.19M, a 40.50% increase from fiscal 2024.
- INTEGER HOLDINGS CORPORATION restructuring costs for fiscal 2024 was $7.25M, a 27.08% decline from fiscal 2023.
- INTEGER HOLDINGS CORPORATION restructuring costs for fiscal 2023 was $9.95M, a 22.89% increase from fiscal 2022.
- INTEGER HOLDINGS CORPORATION restructuring costs for fiscal 2022 was $8.10M.
| Period end | Restructuring Costs 3 month | Restructuring Costs 3 month as first filed | Restructuring Costs 6 month | Restructuring Costs 6 month as first filed | Restructuring Costs 9 month | Restructuring Costs 9 month as first filed | Restructuring Costs 12 month | Restructuring Costs 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-07-03 | $4.40M 10-Q · filed 2026-08-04 | $6.25M 10-Q · filed 2026-08-04 | $10.01M derived: sum of 3 quarters · filed 2026-08-04 | $12.76M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-04-03 | $1.85M 10-Q · filed 2026-04-30 | $5.62M derived: sum of 2 quarters · filed 2026-04-30 | $8.36M derived: sum of 3 quarters · filed 2026-04-30 | $10.94M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $3.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $6.52M derived: sum of 2 quarters · filed 2026-02-23 | $9.09M derived: sum of 3 quarters · filed 2026-08-04 | $10.19M 10-K · filed 2026-02-23 | ||||
| 2025-09-26 | $2.75M 10-Q · filed 2025-10-23 | $5.32M derived: sum of 2 quarters · filed 2026-08-04 | $6.43M 10-Q · filed 2025-10-23 | $7.94M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-27 | $2.58M 10-Q · filed 2026-08-04 | $3.68M 10-Q · filed 2026-08-04 | $5.19M derived: sum of 3 quarters · filed 2026-08-04 | $7.11M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-28 | $1.10M 10-Q · filed 2026-04-30 | $2.62M derived: sum of 2 quarters · filed 2026-04-30 | $4.54M derived: sum of 3 quarters · filed 2026-04-30 | $6.47M derived: sum of 4 quarters · filed 2026-04-30 | ||||
| 2024-12-31 | $1.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $3.43M derived: sum of 2 quarters · filed 2026-02-23 | $5.37M derived: sum of 3 quarters · filed 2026-02-23 | $7.25M 10-K · filed 2026-02-23 | ||||
| 2024-09-27 | $1.92M 10-Q · filed 2025-10-23 | $3.85M derived: sum of 2 quarters · filed 2025-10-23 | $5.74M 10-Q · filed 2025-10-23 | $10.53M derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2024-06-28 | $1.94M 10-Q · filed 2025-07-24 | $2.18M 10-Q · filed 2024-07-25 | $3.82M 10-Q · filed 2025-07-24 | $4.08M 10-Q · filed 2024-07-25 | $8.61M derived: sum of 3 quarters · filed 2026-02-23 | $9.08M derived: sum of 4 quarters · filed 2026-02-23 | ||
| 2024-03-29 | $1.89M 10-Q · filed 2025-04-24 | $1.91M 10-Q · filed 2024-04-25 | $6.67M derived: sum of 2 quarters · filed 2026-02-23 | $7.14M derived: sum of 3 quarters · filed 2026-02-23 | $10.26M derived: sum of 4 quarters · filed 2026-02-23 | |||
| 2023-12-31 | $4.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $5.26M derived: sum of 2 quarters · filed 2026-02-23 | $8.37M derived: sum of 3 quarters · filed 2026-02-23 | $9.95M 10-K · filed 2026-02-23 | $10.44M 10-K · filed 2024-02-20 | |||
| 2023-09-29 | $470.00K 10-Q · filed 2024-10-24 | $703.00K 10-Q · filed 2023-10-26 | $3.59M derived: sum of 2 quarters · filed 2024-10-24 | $5.16M 10-Q · filed 2024-10-24 | $5.62M 10-Q · filed 2023-10-26 | $7.59M derived: sum of 4 quarters · filed 2025-02-20 | ||
| 2023-06-30 | $3.12M 10-Q · filed 2024-07-25 | $4.92M 10-Q · filed 2024-07-25 | $7.12M derived: sum of 3 quarters · filed 2025-02-20 | $10.38M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-03-31 | $1.80M 10-Q · filed 2024-04-25 | $4.01M derived: sum of 2 quarters · filed 2025-02-20 | $7.26M derived: sum of 3 quarters · filed 2025-02-20 | $8.15M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2022-12-31 | $2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $5.46M derived: sum of 2 quarters · filed 2025-02-20 | $6.34M derived: sum of 3 quarters · filed 2025-02-20 | $8.10M 10-K · filed 2025-02-20 | $9.27M 10-K · filed 2023-02-21 | |||
| 2022-09-30 | $3.26M 10-Q · filed 2023-10-26 | $4.14M derived: sum of 2 quarters · filed 2023-10-26 | $5.89M 10-Q · filed 2023-10-26 | |||||
| 2022-07-01 | $884.00K 10-Q · filed 2023-07-27 | $2.64M 10-Q · filed 2023-07-27 | ||||||
| 2022-04-01 | $1.75M 10-Q · filed 2023-04-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |